Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps
    Publication

    Impact survey results after SAFE strategy implementation in 15 local government areas of Kebbi, Sokoto and Zamfara States, Nigeria

    Journal: Ophthalmic Epidemiology

    Summary

    The purpose of this study undertaken 2014-2016 was to determine the prevalence of trachoma after interventions in 15 local government areas (LGAs) of Kebbi, Sokoto and Zamfara States, Nigeria. These LGAs had not necessarily completed the WHO-recommended numbers of MDA rounds indicated by their baseline, but given the chequered history of intervention and the long time period elapsed since the previous round of surveys, refocusing the programme by undertaking fresh estimates was felt to be a good idea. A population-based impact survey was conducted in each LGA using Global Trachoma Mapping Project protocols. The study concluded that progress towards elimination of trachoma had been made in these 15 LGAs. Eight of the 15 LGAs have now attained the elimination target for “trachommatous inflammation-follicular” (TF) while 10 LGAs have attained the elimination target for trichiasis.

    Read the journal article

    Related tags

    Nigeria
    Trachoma
    Eye health
    Publication details
    Date published
    11 September 2019
    Journal
    Ophthalmic Epidemiology
    Countries
    Nigeria
    Themes/conditions
    Trachoma
    Eye health
    Publication details
    Date published
    11 September 2019
    Journal
    Ophthalmic Epidemiology
    Countries
    Nigeria
    Themes/conditions
    Trachoma
    Eye health

    Related publications

    Publication

    Tropical Data: supporting health ministries worldwide to conduct high-quality trachoma surveys

    Publication

    Potential mitigating role of ivermectin on the spread of chlamydia trachomatis by Musca sorbens

    Publication

    Optimising diabetic retinopathy screening at primary health centres in India: a cost-effectiveness analysis

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.